International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
2014 · The Lancet Oncology · 4,761 citations
https://doi.org/10.1016/s1470-2045(14)70442-5
B
Bruno Paiva
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
817
Papers
25.8K
Citations
73
h-index
213
i10-index
Bruno Paiva is an academic researcher from Navarre Institute of Health Research. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & CAR-T cell therapy research. The author has an h-index of 73, co-authored 695 publications.
ORCID: 0000-0003-1977-3815Papers by this author
worksInternational Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
2016 · The Lancet Oncology · 2,843 citations
https://doi.org/10.1016/s1470-2045(16)30206-6
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
2013 · New England Journal of Medicine · 569 citations
https://doi.org/10.1056/nejmoa1300439
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
2020 · Blood Advances · 385 citations
https://doi.org/10.1182/bloodadvances.2020002827
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
2018 · Journal of Hematology & Oncology · 312 citations
https://doi.org/10.1186/s13045-017-0549-1
Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic
2010 · Cytometry Part B Clinical Cytometry · 272 citations
https://doi.org/10.1002/cyto.b.20547
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat